Trials
2 active
4 in total · 2 in the EU
What this is
- How it works
- Adenosine Receptor Agonist FDA class
- How it’s given
- “Regadenoson (Rapiscan®): Single i.v. bolus dose in stress rest CMR”In the company’s words, NCT04604782 on ClinicalTrials.gov
- Tested for
- Myocardial Ischemia, Coronary Artery Disease
- Main trialPhase 1/2
- “This is a multi-centre, open-label, single-dose safety, tolerability and PK-pharmacodynamics (PD) study of the vasodilator regadenoson in 3 paediatric age groups for whom a pharmacologic stress perfusion CMR test is clinically indicated; adolescents aged 12 to \<18 years (Cohort A), children aged 2 to \<12 years (Cohort B), and infants aged 1 to \<24 months and who weigh at least 3 kg (Cohort C). Regadenoson will be used as the pharmacologic stress agent in this study with MPI serving as both surrogate pharmacodynamic marker of the agent (MPR, MBF) and a clinically evaluable examination for…”In the company’s words, NCT04604782 on ClinicalTrials.gov
- Other names
- Lexiscan · CVT 3146
Other drugs for Myocardial Ischemia
- VicagrelJiangsu vcare pharmaceutical technology co., LTD · Phase 3
- T89Tasly · Phase 3
- XTR004Sinotau Pharmaceutical Group · Phase 3
- DalcetrapibDalCor Pharmaceuticals · Phase 3
- EA-230EBI Anti Sepsis BV · Phase 3
- ObicetrapibNewAmsterdam Pharma · Phase 3
Coming up1
- DecPhase 1/2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Recruiting | Dec 2026 | A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients | |
| Phase 3Completed | 15 Jul 2010 | Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) | |
| Phase 2Completed | 2 Jul 2012 | A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT) | |
| Phase 4Authorised | not given | Evaluation of patients with total coronary occlusions with multimodality image. |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026